UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study

Journal of Alzheimer's disease, 2024-01, Vol.98 (3), p.1079

2024

Volltextzugriff (PDF)

Patient and Physician-interpreted Patient Preferences for Administration of Immunoglobulin Therapy in Primary Immunodeficiency Disorder

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB145-AB145

2017

Volltextzugriff (PDF)

Evaluation of Physician-Patient Interactions Regarding Route of Administration for Immunoglobulin Therapy in Primary Immunodeficiency Disease

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB217-AB217

2017

Volltextzugriff (PDF)

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research

Mayo Clinic proceedings, 2009-05, Vol.84 (5), p.436-445

2009

Volltextzugriff (PDF)

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Health economics review, 2020-04, Vol.10 (1), p.8-8, Article 8

2020

Volltextzugriff (PDF)

Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis

American health & drug benefits, 2019-05, Vol.12 (3), p.127-135

2019

Volltextzugriff (PDF)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Health economics review, 2019-07, Vol.9 (22), p.1-10, Article 22

2019

Volltextzugriff (PDF)

Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?

Journal of the neurological sciences, 2020-01, Vol.408, p.116497, Article 116497

2020

Volltextzugriff (PDF)

Examining the Interrelationship of Migraine Onset, Duration, and Time to Treatment

Headache, 2012-03, Vol.52 (3), p.363-373

2012

Volltextzugriff (PDF)

The Dilemma of Diabetes in Chronic Inflammatory Demyelinating Polyneuropathy

Journal of diabetes and its complications, 2016-09, Vol.30 (7), p.1401-1407

2016

Volltextzugriff (PDF)

The Development of a Survey to Measure Completeness of Response to Migraine Therapy

Headache, 2012-04, Vol.52 (4), p.550-572

2012

Volltextzugriff (PDF)

Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study

Headache, 2013-11, Vol.53 (10), p.1548-1563

2013

Volltextzugriff (PDF)

Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's disease

Expert review of neurotherapeutics, 2022-10, Vol.22 (10), p.863-873

2022

Volltextzugriff (PDF)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.2389-2397

2020

Volltextzugriff (PDF)

Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality

Blood advances, 2022-10, Vol.6 (20), p.5655-5658

2022

Volltextzugriff (PDF)

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research

Mayo Clinic proceedings, 2009, Vol.84 (5), p.436-445

2009

Volltextzugriff (PDF)

Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine

Pediatrics (Evanston), 2012-06, Vol.129 (6), p.e1411

2012

Volltextzugriff (PDF)

Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination

Headache, 2014-04, Vol.54 (4), p.640-654

2014

Volltextzugriff (PDF)

Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States

Journal of medical economics, 2018-08, Vol.21 (8), p.762-769

2018

Volltextzugriff (PDF)

A Cross-Sectional Survey to Assess the Migraineur's Medication Decision-Making Beliefs: Determining When a Migraine Is Triptan-Worthy

Headache, 2013-07, Vol.53 (7), p.1134-1146

2013

Volltextzugriff (PDF)

Long-Term Evaluation of Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents

Headache, 2011-10, Vol.51 (9), p.1374-1387

2011

Volltextzugriff (PDF)

Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US

Patient preference and adherence, 2019-01, Vol.13, p.649-655

2019

Volltextzugriff (PDF)

Assessing the Impact of Migraine Onset on Work Productivity

Journal of occupational and environmental medicine, 2011-01, Vol.53 (1), p.74-81

2011

Volltextzugriff (PDF)

Sumatriptan-Naproxen Sodium for Menstrual Migraine and Dysmenorrhea: Satisfaction, Productivity, and Functional Disability Outcomes

Headache, 2011-05, Vol.51 (5), p.664-673

2011

Volltextzugriff (PDF)

Longitudinal Change in Migraine Headache-Days and Indirect Cost Consequences

Journal of occupational and environmental medicine, 2011-05, Vol.53 (5), p.478-487

2011

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Humans
(21)
Male
(15)
Female
(12)
Migraine
(12)
Middle Aged
(11)
Neurosciences & Neurology
(11)
Adult
(10)
Clinical Neurology
(10)
Adolescent
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Migraine Disorders - Drug Therapy
(8)
Neurology
(8)
Vascular Diseases And Vascular Malformations Of The Nervous System
(8)
Aged
(7)
General & Internal Medicine
(6)
Health Care Sciences & Services
(6)
Medicine, General & Internal
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study

Patient and Physician-interpreted Patient Preferences for Administration of Immunoglobulin Therapy in Primary Immunodeficiency Disorder

Evaluation of Physician-Patient Interactions Regarding Route of Administration for Immunoglobulin Therapy in Primary Immunodeficiency Disease

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?

Examining the Interrelationship of Migraine Onset, Duration, and Time to Treatment

The Dilemma of Diabetes in Chronic Inflammatory Demyelinating Polyneuropathy

The Development of a Survey to Measure Completeness of Response to Migraine Therapy

Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study

Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's disease

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US

Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research

Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine

Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination

Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States

A Cross-Sectional Survey to Assess the Migraineur's Medication Decision-Making Beliefs: Determining When a Migraine Is Triptan-Worthy

Long-Term Evaluation of Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents

Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US

Assessing the Impact of Migraine Onset on Work Productivity

Sumatriptan-Naproxen Sodium for Menstrual Migraine and Dysmenorrhea: Satisfaction, Productivity, and Functional Disability Outcomes

Longitudinal Change in Migraine Headache-Days and Indirect Cost Consequences

Suchergebnisse filtern